Clinical Trial Update: Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70 [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating treatment for primary plasma cell leukemia in patients under 70.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Leukemia

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED